Biblio
Export 2657 results:
Author Title Type [ Year
Filters: First Letter Of Last Name is S [Clear All Filters]
“Tau Immunotherapies for Alzheimer's Disease and Related Tauopathies: Status of Trials and Insights from Preclinical Studies.”, J Alzheimers Dis, vol. 101, no. s1, pp. S129-S140, 2024.
, “There are dementia patients in Gaza too.”, J Alzheimers Dis, vol. 102, no. 2, pp. 317-320, 2024.
, “There are dementia patients in Gaza too.”, J Alzheimers Dis, vol. 102, no. 2, pp. 317-320, 2024.
, “Unveiling New Strategies Facilitating the Implementation of Artificial Intelligence in Neuroimaging for the Early Detection of Alzheimer's Disease.”, J Alzheimers Dis, vol. 99, no. 1, pp. 1-20, 2024.
, “Voluntary wheel running decreases amyloidogenic pathway and rescues cognition and mitochondrial energy metabolism in middle-aged female 3xTg-AD mouse model of Alzheimer's disease.”, J Alzheimers Dis, vol. 102, no. 2, pp. 424-436, 2024.
, “Alzheimer's disease-related cortical proteins modify the association of brain insulin signaling with cognitive decline.”, J Alzheimers Dis, vol. 104, no. 3, pp. 667-677, 2025.
, “Alzheimer's disease-related cortical proteins modify the association of brain insulin signaling with cognitive decline.”, J Alzheimers Dis, vol. 104, no. 3, pp. 667-677, 2025.
, “Baseline associations of office and ambulatory blood pressure monitoring with cognitive function and dementia prevalence.”, J Alzheimers Dis, p. 13872877251322400, 2025.
, “Baseline associations of office and ambulatory blood pressure monitoring with cognitive function and dementia prevalence.”, J Alzheimers Dis, p. 13872877251322400, 2025.
, “Baseline associations of office and ambulatory blood pressure monitoring with cognitive function and dementia prevalence.”, J Alzheimers Dis, p. 13872877251322400, 2025.
, “Brain-penetrant histone deacetylase inhibitor RG2833 improves spatial memory in females of an Alzheimer's disease rat model.”, J Alzheimers Dis, p. 13872877251314777, 2025.
, “Cost-effectiveness of diagnosing and treating patients with early Alzheimer's disease with anti-amyloid treatment in a clinical setting.”, J Alzheimers Dis, p. 13872877251323231, 2025.
, “Cost-effectiveness of diagnosing and treating patients with early Alzheimer's disease with anti-amyloid treatment in a clinical setting.”, J Alzheimers Dis, p. 13872877251323231, 2025.
, “Cost-effectiveness of diagnosing and treating patients with early Alzheimer's disease with anti-amyloid treatment in a clinical setting.”, J Alzheimers Dis, p. 13872877251323231, 2025.
, “Down syndrome and Alzheimer's disease: Oxidative stress in the neurodegenerative process.”, J Alzheimers Dis, p. 13872877251326291, 2025.
, “Dynamic PET imaging in patients with unilateral carotid occlusion shows lateralized cerebral hypoperfusion, but no amyloid binding.”, J Alzheimers Dis, p. 13872877251329593, 2025.
, “EEG biomarkers for Alzheimer's disease: A novel automated pipeline for detecting and monitoring disease progression.”, J Alzheimers Dis, p. 13872877251327754, 2025.
, “EEG biomarkers for Alzheimer's disease: A novel automated pipeline for detecting and monitoring disease progression.”, J Alzheimers Dis, p. 13872877251327754, 2025.
, “EEG biomarkers for Alzheimer's disease: A novel automated pipeline for detecting and monitoring disease progression.”, J Alzheimers Dis, p. 13872877251327754, 2025.
, “Impact of obesity on neuropsychiatric symptoms in Alzheimer's disease: Insights from the ADNI cohort.”, J Alzheimers Dis, vol. 105, no. 3, pp. 776-790, 2025.
, “Interactive effects of ɛ4 status and vascular burden on white matter microstructural integrity in aging with and without neurocognitive decline.”, J Alzheimers Dis, p. 13872877251320660, 2025.
, “Leptin, adiponectin, body mass index, and incident cognitive impairment.”, J Alzheimers Dis, p. 13872877251326060, 2025.
, “Leptin, adiponectin, body mass index, and incident cognitive impairment.”, J Alzheimers Dis, p. 13872877251326060, 2025.
, “Lipopolysaccharides from indirectly induce neuronal GSK3β-dependent synaptic defects and cause cognitive decline in a low-amyloid-β-concentration environment in Alzheimer's disease.”, J Alzheimers Dis, p. 13872877251326879, 2025.
, ,